NIH to meet over use of hydroxyurea for sickle cell disease

Article

NIH to meet over use of hydroxyurea for sickle cell disease

How effective is the use of hydroxyurea to treat sickle cell anemia? The National Institutes of Health will be holding a consensus conference to address this issue. Sickle cell disease is an inherited blood disorder that affects up to 75,000 people in the United States, many of whom are from sub-Saharan Africa and other areas. The

Recent Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.